Gut and Liver

The Korean Association for the Study of the Liver (대한간학회)
권호 표지
DOI QR코드

DOI QR Code

Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea

  • Cho, Soo-Jeong (Research Institute and Hospital, National Cancer Center) ;
  • Choi, Il-Ju (Research Institute and Hospital, National Cancer Center) ;
  • Kim, Chan-Gyoo (Research Institute and Hospital, National Cancer Center) ;
  • Lee, Jong-Yeul (Research Institute and Hospital, National Cancer Center) ;
  • Kook, Myeong-Cherl (Research Institute and Hospital, National Cancer Center) ;
  • Seong, Moon-Woo (Research Institute and Hospital, National Cancer Center) ;
  • Park, Sook-Ryun (Research Institute and Hospital, National Cancer Center) ;
  • Lee, Jong-Seok (Research Institute and Hospital, National Cancer Center) ;
  • Kim, Young-Woo (Research Institute and Hospital, National Cancer Center) ;
  • Ryu, Keun-Won (Research Institute and Hospital, National Cancer Center) ;
  • Lee, Jun-Ho (Research Institute and Hospital, National Cancer Center) ;
  • Nam, Byung-Ho (Center for Clinical Trials, National Cancer Center) ;
  • Park, Young-Iee (Research Institute and Hospital, National Cancer Center)
  • Published : 2010.12.31
⟨ Previous Next ⟩

Abstract

Background/Aims: To evaluate the association between Helicobacter pylori (H. pylori) infection and gastric cancer (GC) according to tumor subtype in Korea. Methods: H. pylori status was determined serologically using the enzyme-linked immunosorbent assay. In total, 2,819 patients with GC and 562 healthy controls were studied. A logistic regression method was used after adjusting for possible confounders. Results: The prevalence of H. pylori infection was significantly higher in the GC patients (84.7%) than in the controls (66.7%) (odds ratio [OR], 3.13; 95% confidence interval [CI], 2.46-3.97). The adjusted OR was significantly higher in H.-pylori-infected patients aged <60 years (OR, 4.69; 95% CI, 3.44-6.38) than in those aged ${\geq}$60 years (OR, 1.48; 95% CI, 0.88-2.46; p<0.001). Subgroup analyses revealed no differences in seroprevalence between early gastric cancer (84.8%; OR, 3.01; 95% CI, 2.27-4.01) and advanced gastric cancer (84.6%; OR, 2.94; 95% CI, 2.24-3.85), cardia cancer (83.8%; OR, 2.98; 95% CI, 2.16-4.02) and noncardia cancer (84.8%; OR, 3.17; 95% CI, 2.48-4.04), and differentiated carcinoma (82.7%; OR, 2.99; 95% CI, 2.21-4.04) and undifferentiated carcinoma (86.8%; OR, 3.05; 95% CI, 2.32-4.00). Conclusions: The seroprevalence of H. pylori was higher in GC patients than in healthy controls, especially in younger patients. H. pylori infection is associated with GC, regardless of the tumor location, stage, or differentiation.

Keywords

References

  1. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000;92:1607-1612. https://doi.org/10.1093/jnci/92.19.1607
  2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789. https://doi.org/10.1056/NEJMoa001999
  3. Crespi M, Citarda F. Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 1996;31:1041-1046. https://doi.org/10.3109/00365529609036884
  4. Shin A, Shin HR, Kang D, Park SK, Kim CS, Yoo KY. A nested case-control study of the association of Helicobacter pylori infection with gastric adenocarcinoma in Korea. Br J Cancer 2005;92:1273-1275. https://doi.org/10.1038/sj.bjc.6602467
  5. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992;33:429-431. https://doi.org/10.1136/gut.33.4.429
  6. Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol 2006;12:1346-1351.
  7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. https://doi.org/10.3322/canjclin.55.2.74
  8. Shin HR, Won YJ, Jung KW, et al. Nationwide cancer incidence in Korea, 1999-2001: first result using the national cancer incidence database. Cancer Res Treat 2005;37:325-331. https://doi.org/10.4143/crt.2005.37.6.325
  9. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-340. https://doi.org/10.1111/j.1523-5378.2007.00504.x
  10. Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-975. https://doi.org/10.1046/j.1440-1746.2001.02568.x
  11. Chang WK, Kim HY, Kim DJ, et al. Association between Helicobacter pylori infection and the risk of gastric cancer in the Korean population: prospective case-controlled study. J Gastroenterol 2001;36:816-822. https://doi.org/10.1007/s005350170003
  12. Lee SA, Kang D, Shim KN, Choe JW, Hong WS, Choi H. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003;13:162-168. https://doi.org/10.2188/jea.13.162
  13. Kim HY, Cho BD, Chang WK, et al. Helicobacter pylori infection and the risk of gastric cancer among the Korean population. J Gastroenterol Hepatol 1997;12:100-103. https://doi.org/10.1111/j.1440-1746.1997.tb00391.x
  14. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131. https://doi.org/10.1056/NEJM199110173251603
  15. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-1452. https://doi.org/10.1093/jnci/djj393
  16. Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001;93:226-233. https://doi.org/10.1093/jnci/93.3.226
  17. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991;83:640-643. https://doi.org/10.1093/jnci/83.9.640
  18. Hansson LR, Engstrand L, Nyren O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885-888. https://doi.org/10.1016/0016-5085(95)90398-4
  19. Kato M, Asaka M, Shimizu Y, Nobuta A, Takeda H, Sugiyama T. Relationship between Helicobacter pylori infection and the prevalence, site and histological type of gastric cancer. Aliment Pharmacol Ther 2004;20 Suppl 1:85-89.
  20. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179. https://doi.org/10.1016/S0016-5085(98)70422-6
  21. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 2003;106:953-960. https://doi.org/10.1002/ijc.11306
  22. Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57:298-305. https://doi.org/10.1136/gut.2007.137364
  23. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127-139. https://doi.org/10.1007/BF02468883
  24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
  25. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998;1:10-24.
  26. Eom HS, Kim PS, Lee JW, et al. Evaluation of four commercial enzyme immunoassay for detection of Helicobacter pylori infection. Korean J Gastroenterol 2001;37:312-318.
  27. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
  28. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353. https://doi.org/10.1136/gut.49.3.347
  29. Karnes WE Jr, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-174.
  30. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007;102:1789-1798. https://doi.org/10.1111/j.1572-0241.2007.01335.x
  31. Tsukuma H, Mishima T, Oshima A. Prospective study of "early" gastric cancer. Int J Cancer 1983;31:421-426. https://doi.org/10.1002/ijc.2910310405
  32. Genta RM, Gurer IE, Graham DY, et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996;111:1206-1211. https://doi.org/10.1053/gast.1996.v111.pm8898634
  33. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-590.
  34. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:388-396. https://doi.org/10.1093/jnci/djh057
  35. Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 1998;93:1800-1802. https://doi.org/10.1111/j.1572-0241.1998.00523.x
  36. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 2005;54 Suppl 1:i1-i5.
  37. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053. https://doi.org/10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2
  38. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002;14:115-122. https://doi.org/10.1097/00042737-200202000-00004
  39. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
  40. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143. https://doi.org/10.1002/ijc.11680
  41. Tatsuta M, Iishi H, Okuda S, Taniguchi H, Yokota Y. The association of Helicobacter pylori with differentiated-type early gastric cancer. Cancer 1993;72:1841-1845. https://doi.org/10.1002/1097-0142(19930915)72:6<1841::AID-CNCR2820720608>3.0.CO;2-I
  42. Iseki K, Tatsuta M, Iishi H, Baba M, Ishiguro S. Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test. Gut 1998;42:20-23. https://doi.org/10.1136/gut.42.1.20
  43. Sasazuki S, Inoue M, Iwasaki M, et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1341-1347. https://doi.org/10.1158/1055-9965.EPI-05-0901
  44. Craanen ME, Blok P, Dekker W, Tytgat GN. Helicobacter pylori and early gastric cancer. Gut 1994;35:1372-1374. https://doi.org/10.1136/gut.35.10.1372
  45. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004;5:133-139.
  46. Nakamura T, Yao T, Niho Y, Tsuneyoshi M. A clinicopathological study in young patients with gastric carcinoma. J Surg Oncol 1999;71:214-219. https://doi.org/10.1002/(SICI)1096-9098(199908)71:4<214::AID-JSO2>3.0.CO;2-D
  47. Lo SS, Kuo HS, Wu CW, et al. Poorer prognosis in young patients with gastric cancer? Hepatogastroenterology 1999;46:2690-2693.
  48. Wang JY, Hsieh JS, Huang CJ, Huang YS, Huang TJ. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. J Surg Oncol 1996;63:36-40. https://doi.org/10.1002/(SICI)1096-9098(199609)63:1<36::AID-JSO6>3.0.CO;2-R
  49. Yokota T, Takahashi N, Teshima S, et al. Early gastric cancer in the young: clinicopathological study. Aust N Z J Surg 1999;69:443-446. https://doi.org/10.1046/j.1440-1622.1999.01553.x
  50. Medina-Franco H, Heslin MJ, Cortes-Gonzalez R. Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 2000;7:515-519. https://doi.org/10.1007/s10434-000-0515-x
  51. Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients. World J Gastroenterol 2005;11:22-26.
  52. Bani-Hani KE. Clinicopathological comparison between young and old age patients with gastric adenocarcinoma. Int J Gastrointest Cancer 2005;35:43-52. https://doi.org/10.1385/IJGC:35:1:043
  53. Kim JH, Boo YJ, Park JM, et al. Incidence and long-term outcome of young patients with gastric carcinoma according to sex: does hormonal status affect prognosis? Arch Surg 2008;143:1062-1067. https://doi.org/10.1001/archsurg.143.11.1062
  54. Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today 1992;22:421-425. https://doi.org/10.1007/BF00308791
  55. Furukawa H, Iwanaga T, Hiratsuka M, et al. Gastric cancer in young adults: growth accelerating effect of pregnancy and delivery. J Surg Oncol 1994;55:3-6. https://doi.org/10.1002/jso.2930550103
  56. Maeta M, Yamashiro H, Oka A, Tsujitani S, Ikeguchi M, Kaibara N. Gastric cancer in the young, with special reference to 14 pregnancy-associated cases: analysis based on 2,325 consecutive cases of gastric cancer. J Surg Oncol 1995;58:191-195. https://doi.org/10.1002/jso.2930580310
  57. Lindblad M, Ye W, Rubio C, Lagergren J. Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 2004;13:2203-2207.
  58. Romero-Gallo J, Perez-Perez GI, Novick RP, Kamath P, Norbu T, Blaser MJ. Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens. Clin Diagn Lab Immunol 2002;9:1313-1317.
  59. Chang YW, Han YS, Lee DK, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002;101:469-474. https://doi.org/10.1002/ijc.10637
  60. Klaamas K, Held M, Wadstrom T, Lipping A, Kurtenkov O. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996;67:1-5. https://doi.org/10.1002/(SICI)1097-0215(19960703)67:1<1::AID-IJC1>3.0.CO;2-0

Cited by

  1. Effect ofHelicobacter pyloriInfection on p16, p53, CEA, EGFR Expression in Gastric Neoplasia vol.11, pp.1, 2010, https://doi.org/10.7704/kjhugr.2011.11.1.45
  2. Knowledge and Attitudes of Junior Medical Doctors towards Gastric Cancer vol.21, pp.3, 2010, https://doi.org/10.1177/201010581202100302
  3. Diagnosis and Treatment of Helicobacter Pylori Infection: Korean and Overseas Guidelines vol.89, pp.2, 2015, https://doi.org/10.3904/kjm.2015.89.2.157
  4. Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population vol.2018, pp.None, 2010, https://doi.org/10.1155/2018/7132868
  5. KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition vol.24, pp.24, 2010, https://doi.org/10.1158/1078-0432.ccr-17-1679
  6. Helicobacter pylori Is Associated With Precancerous and Cancerous Lesions of the Gastric Cardia Mucosa: Results of a Large Population-Based Study in China vol.10, pp.None, 2010, https://doi.org/10.3389/fonc.2020.00205
  7. Microbiological evidences for gastric cardiac microflora dysbiosis inducing the progression of inflammation vol.35, pp.6, 2020, https://doi.org/10.1111/jgh.14946
  8. Predictive Effect of Helicobacter pylori in Gastric Carcinoma Development: Systematic Review and Quantitative Evidence Synthesis vol.8, pp.1, 2010, https://doi.org/10.3390/medicines8010001
  9. Population Attributable Fraction of Helicobacter pylori Infection-Related Gastric Cancer in Korea: A Meta-Analysis vol.53, pp.3, 2010, https://doi.org/10.4143/crt.2020.610
  10. Helicobacter pylori in gastric cancer: Features of infection and their correlations with long-term results of treatment vol.27, pp.37, 2021, https://doi.org/10.3748/wjg.v27.i37.6290